Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

Yuki Sunagawa,Suguru Yamada,Yusuke Sato,Daishi Morimoto,Fuminori Sonohara,Hideki Takami,Yoshikuni Inokawa,Masamichi Hayashi,Mitsuro Kanda,Chie Tanaka,Daisuke Kobayashi,Goro Nakayama,Masahiko Koike,Michitaka Fujiwara,Tsutomu Fujii,Yasuhiro Kodera

Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

2019

Yuki Sunagawa
Suguru Yamada
Yusuke Sato
Daishi Morimoto
Fuminori Sonohara
Hideki Takami
Yoshikuni Inokawa
Masamichi Hayashi
Mitsuro Kanda
Chie Tanaka
Daisuke Kobayashi
Goro Nakayama
Masahiko Koike
Michitaka Fujiwara
Tsutomu Fujii
Yasuhiro Kodera

Background This study aimed to explore the impact of serum tumor markers on survival for patients with pancreatic cancer (PC) who received initial systemic therapy (IST) followed by surgery.

Keywords:

Oncology
Systemic therapy
Medicine
Internal medicine
General surgery
Pancreatic cancer
Monoclonal
Survival analysis
Surgical oncology
Hazard ratio
Confidence interval
Gastroenterology
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations